Search results for abx831382

Galcanezumab, Abbexa, abx831382

Galcanezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CALCA/CGRP1/CALCB/CGRP2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. LY2951742/galcanezumab is a fully humanized monoclonal antibody against human calcitonin gene-related peptide (CGRP) that is developed by ELi Lilly and Company. This therapy is given as a single subcutaneous injection twice a month and ongoing clinical trials for the agent are for episodic and chronic migraine as well as cluster headaches.